Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 12, 2006, Pages 1821-1825

  Konishi, Masayoshi ^a   Iwasa, Motoh ^b   Araki, Jun ^b   Kobayashi, Yoshinao ^b   Katsuki, Akira ^b   Sumida, Yasuhiro ^b   Nakagawa, Naoki ^c   Kojima, Yuji ^d   Watanabe, Shozo ^a   Adachi, Yukihiko ^b   Kaito, Masahiko ^b  

^a MIE UNIVERSITY   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c MIE UNIVERSITY   (Japan)

^d ISE RED CROSS HOSPITAL   (Japan)

Author keywords

8 isoprostane; Chronic hepatitis C; Interferon; Lipid peroxidation; Non alcoholic fatty liver disease

Indexed keywords

8 ISOPROSTANE; CHOLESTEROL; PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADOLESCENT; ADULT; AFFINITY CHROMATOGRAPHY; AGED; ARTICLE; BODY MASS; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS C; HUMAN; IRON METABOLISM; LIPID PEROXIDATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL;

EID: 33750097483     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04420.x     Document Type: Article

References (34)

1. Farinati F, Cardin R, De Maria N et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J. Hepatol. 1995; 22: 449-56.
2. Larrea E, Beloqui O, Munoz-Navas MA, Civeira MP, Prieto J. Superoxide dismutase in patients with chronic hepatitis C virus infection. Free Radic. Biol. Med. 1998; 24: 1235-41.
3. Sumida Y, Nakashima T, Yoh T et al. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J. Hepatol. 2000; 33: 616-22.
4. Gopaul NK, Anggard EE, Mallet AI, Betteridge DJ, Wolff SP, Nourooz-Zadeh J. Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 1995; 368: 225-9.
5. Morrow JD, Frei B, Longmire AW et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N. Engl. J. Med. 1995; 332: 1198-203.
6. Sampson MJ, Gopaul N, Davies IR, Hughes DA, Carrier MJ. Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes. Diabetes Care 2002; 25: 537-41.
7. Katsuki A, Sumida Y, Urakawa H et al. Increased oxidative stress is associated with elevated plasma levels of adrenomedullin in hypertensive patients with type 2 diabetes. Diabetes Care 2003; 26: 1642-3.
8. Morrow JD. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler. Thromb. Vasc. Biol. 2005; 25: 279-86.
9. Ichida F, Tsuji T, Omata M et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int. Hepatol. Commun. 1996; 6: 112-19.
10. Kaplowitz N, Tsukamoto H. Oxidative stress and liver disease. Prog. Liver Dis. 1996; 14: 131-59.
11. Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic. Biol. Med. 2003; 34: 1-10.
12. Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr. Rev. 2002; 60: 289-93.
13. Kmiec Z. Cooperation of liver cells in health and disease. Adv. Anat. Embryol. Cell Biol. 2001; 161: 1-151.
14. Arteel GE. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 2003; 124: 778-90.
15. Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J. Gastroenterol. Hepatol. 2003; 18: 891-902.
16. Kitada T, Seki S, Iwai S, Yamada T, Sakaguchi H, Wakasa K. In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease. J. Hepatol. 2001; 35: 613-18.
17. Paradis V, Mathurin P, Kollinger M et al. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J. Clin. Pathol. 1997; 50: 401-6.
18. De Maria N, Colantoni A, Fagiuoli S et al. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic. Biol. Med. 1996; 21: 291-5.
19. Jain SK, Pemberton PW, Smith A et al. Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J. Hepatol. 2002; 36: 805-11.
20. Sumida Y, Nakashima T, Yoh T et al. Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. J. Hepatol. 2003; 38: 32-8.
21. Davi G, Ciabattoni G, Consoli A et al. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 1999; 99: 224-9.
22. Devaraj S, Hirany SV, Burk RF, Jialal I. Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetes. Clin. Chem. 2001; 47: 1974-9.
23. Cipollone F, Ciabattoni G, Patrignani P et al. Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina. Circulation 2000; 102: 1007-13.
24. Walsh SW, Vaughan JE, Wang Y, Roberts LJ. Placental isoprostane is significantly increased in preeclampsia. FASEB J. 2000; 14: 1289-96.
25. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am. J. Respir. Crit. Care Med. 1999; 160: 216-20.
26. Aboutwerat A, Pemberton PW, Smith A et al. Oxidant stress is a significant feature of primary biliary cirrhosis. Biochim. Biophys. Acta 2003; 1637: 142-50.
27. Urakawa H, Katsuki A, Sumida Y et al. Oxidative stress is associated with adiposity and insulin resistance in men. J. Clin. Endocrinol. Metab. 2003; 88: 4673-6.
28. Davi G, Alessandrini P, Mezzetti A et al. In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 3230-5.
29. Sumida Y, Nakashima T, Yoh T et al. Serum thioredoxin elucidates the significance of serum ferritin as a marker of oxidative stress in chronic liver diseases. Liver 2001; 21: 295-9.
30. Moriya K, Fujie H, Shintani Y et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 1998; 4: 1065-7.
31. Moriya K, Nakagawa K, Santa T et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res. 2001; 61: 4365-70.
32. Okuda M, Li K, Beard MR et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002; 122: 366-75.
33. Morisco F, Verde V, Fogliano V et al. Oxidative status in chronic hepatitis C: the influence of antiviral therapy and prognostic value of serum hydroperoxide assay. Free Radic. Res. 2004; 38: 573-80.
34. Mahmood S, Yamada G, Niiyama G et al. Effect of vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C. Free Radic. Res. 2003; 37: 781-5.